Latest news
Featured
Hikma delivers a solid H1 performance and re-affirms expectations for strong growth in the second half
Press Release, Financial Results
07 August 2025
- Hikma announces CEO change and Board appointment Press Release, Corporate 15 December 2025 Hikma announces CEO change and Board appointment
- Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US Press Release, Product 08 December 2025 Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
- Hikma signs an exclusive agreement with DGI Group to bring Claritag® to the MENA region Press Release, Business Development 19 November 2025 Hikma signs an exclusive agreement with DGI Group to bring Claritag® to the MENA region
- Hikma confirms 2025 guidance and updates medium-term growth outlook Press Release, Financial Results 06 November 2025 Hikma confirms 2025 guidance and updates medium-term growth outlook
Related content